Rapid flare of immune thrombocytopenia after stopping ibrutinib in a patient with chronic lymphocytic leukemia

Leuk Lymphoma. 2018 Jul;59(7):1738-1741. doi: 10.1080/10428194.2017.1387907. Epub 2017 Oct 30.

Authors

Rino Sato¹, Jillian Jacob², Sameh Gaballa²

Affiliations

¹ a Department of Internal Medicine , Thomas Jefferson University , Philadelphia , PA , USA.
² b Department of Medical Oncology, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation , Thomas Jefferson University , Philadelphia , PA , USA.

PMID: 29081253
DOI: 10.1080/10428194.2017.1387907

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adenine / analogs & derivatives
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Biomarkers
Humans
Immunoglobulins, Intravenous / therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell / complications*
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
Male
Middle Aged
Piperidines
Platelet Count
Protein Kinase Inhibitors / adverse effects*
Protein Kinase Inhibitors / therapeutic use
Purpura, Thrombocytopenic, Idiopathic / diagnosis
Purpura, Thrombocytopenic, Idiopathic / etiology*
Purpura, Thrombocytopenic, Idiopathic / therapy
Pyrazoles / adverse effects*
Pyrazoles / therapeutic use
Pyrimidines / adverse effects*
Pyrimidines / therapeutic use
Treatment Outcome

Substances

Antineoplastic Agents
Biomarkers
Immunoglobulins, Intravenous
Piperidines
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
ibrutinib
Adenine